Amsterdam UMC, location VUmc
Amsterdam, 1081HV, Netherlands
NCT Number: NCT07291271
Tumors in the liver can be treated using percutaneous ablation. At the Amsterdam UMC, this procedure is often performed under CT guidance by an interventional radiologist. The available ablation techniques include thermal ablation (microwave ablation (MWA) and radiofrequency ablation (RFA)) and non-thermal ablation (irreversible electroporation (IRE)). Thermal ablation is performed under general anesthesia or deep sedation, whereas non-thermal ablation is always performed under general anesthesia.
Flow-controlled ventilation (FCV) is a ventilation technique in which increased diaphragm stability is observed due to a continuous flow during both inspiration and expiration. This contrasts with volume- or pressure-controlled ventilation, where active inspiration is followed by passive expiration through an increase in pressure or flow, leading to greater diaphragm movement during the ventilation cycle. With volume- or pressure-controlled ventilation, diaphragm position fluctuates between inspiration and expiration, requiring temporary pauses in ventilation (apnea; allowing the diaphragm to become motionless) during ablation needle positioning.
During volume- or pressure-controlled ventilation and the associated apnea periods, increased formation of atelectasis is often observed. This results in changes in diaphragm position during and after each apnea, which can complicate accurate needle placement. With FCV, apnea is not necessary-the continuous flow results in minimal diaphragm excursion and can be maintained throughout the entire procedure without interruption.
Both ventilation modes are currently used during CT-guided percutaneous ablation of liver and pancreatic tumors. However, the choice of ventilation technique presently lies with the attending anesthesiologist. In practice, some anesthesiologists prefer volume- or pressure-controlled ventilation, as these are traditionally the most commonly used modes. Others opt for FCV due to its minimal effect on diaphragm excursion and its potentially beneficial effects on atelectasis formation and intraprocedural image quality.
Given the subdiaphragmatic location of both organs and the presence of critical surrounding structures that must be preserved during the procedure, interventional radiologists find FCV particularly advantageous. Moreover, continuous ventilation without apnea is preferred by anesthesiologists, as it avoids periods of reduced oxygenation.
FCV is an already approved ventilation technique at Amsterdam UMC and is used during percutaneous ablations, surgeries performed by ENT and pulmonary specialists, and in the intensive care unit for critically ill patients. Through this study, the investigators aim to evaluate the use of FCV as a ventilation technique during CT-guided percutaneous ablations of liver tumors and to compare it with volume- or pressure-controlled ventilation.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Amsterdam, 1081HV, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Flow controlled ventilation will be investigated during CT-guided percutaneous ablation of liver tumors
Time frame: During the CT-guided percutaneous ablation procedure
Switch if deemed necessary by the anesthesiologist performing the ventilation.
Time frame: During the ablation procedure
Comparison of diaphragm movement by segmenting the pulmonary bases in pre- and post-ablation images and assessment of intra-procedural atelectasis formation.
Time frame: Directly after the ablation procedure
Completed by the interventional radiologist to assess the suitability of FCV for the procedure.
Score can vary from 0-25, where 25 is the highest score.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Other
Flow-controlled Ventilation During Percutaneous CT-guided Liver Tumor Ablation
Acronym: EVOLVE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04014920
Body Weight, Intensive Care Unit
Montpellier, Herault, France
View Trial DetailsNCT03657368
Orthopedic Surgery, Pathologic Processes
Cleveland, Ohio, United States
View Trial DetailsNCT04376918
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Jerusalem, Israel
View Trial DetailsNCT06737003
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Cairo, Egypt
View Trial Details